Volume 3

Issue 1

Article 2

12-14-2017

Illness Perception in Patients with Thalassemia in Nablus,
Palestine: A Pilot study
Ansam Sawalha
Dina Jodeh
dinajodeh65@yahoo.com

Fatima Helo
fatima_helo@yahoo.com

Waleed M. Sweileh

Follow this and additional works at: https://pmpj.najah.edu/journal

Recommended Citation
Sawalha, Ansam; Jodeh, Dina; Helo, Fatima; and Sweileh, Waleed M. (2017) "Illness Perception in Patients
with Thalassemia in Nablus, Palestine: A Pilot study," Palestinian Medical and Pharmaceutical Journal:
Vol. 3: Iss. 1, Article 2.
Available at: https://pmpj.najah.edu/journal/vol3/iss1/2

This Research article is brought to you for free and open access by Palestinian Medical and Pharmaceutical
Journal. It has been accepted for inclusion in Palestinian Medical and Pharmaceutical Journal by an authorized
editor of Palestinian Medical and Pharmaceutical Journal. For more information, please contact
mqneibi@najah.edu.

Palestinian Medical and Pharmaceutical Journal (PMPJ). 2018; 3(1): 7-13

Illness Perception in Patients with Thalassemia in Nablus, Palestine: A Pilot study
Ansam Sawalha1*, Dina Jodeh2, Diana Jodeh2, Fatima Helo2, Waleed Sweileh1
1: Department of Pharmacology and Physiology, Faculty of Medicine and Allied Health, AnNajah National University, Nablus, Palestine. 2: Faculty of Medicine and Allied Health,
An-Najah National University, Nablus, Palestine.
*Corresponding author: ansam@najah.edu
Received: (16/9/2017), Accepted: (14/12/2017)
Abstract
Thalassemia is a hemoglobinopathy which is results from a gene mutation in α or β chain. It has the
preeminent prevalence in Mediterranean, tropical areas and regions near the equator. Thalassemia is one
of the most prevalent genetic blood disorders in the world. Research pertaining to patient perception of
thalassemia is limited in Palestine. Our study is the first one nationwide that aims to assess the perceptions and attitudes toward thalassemia and thalassemia treatment. A cross-sectional, non-interventional,
descriptive study design was used. A convenient sample of 113 thalassemic patients attending the
specialty clinic at Al-Watani hospital, Nablus, Palestine was included. We used a previously published
Brief-Illness Perception Questionnaire (B-IPQ) version to achieve the objectives of the study. A total of
113 thalassemic patients aged 12-70 (average 21.0±9.5 years) were recruited, 51.3% were females, and
they have been diagnosed since 19.4± 7.4 years. A bit less than half (44.2%) had college education; the
rest had high school or less level. The largest category (55.8%) live in villages, 57.5% of them had a
consanguineous marriage, yet almost all (98.2%) of the participants did not have any other diseases. As
for the perception aspects, participants believe their disease as chronic, and that the treatment can
control their disease to a significant extent (treatment control) (median = 10 for both). As for personal
control, it was high with a median of 8, and the same value was also achieved for understanding the
disease. The remaining components of the B-IPQ were found to be 3 indicating a low score Data
indicated that the participants perceive their disease as chronic with treatment being able to control.
They also believe that they have some control over the disease, and that it has minimal effect on their
quality of life. More steps should be taken to focus on the psychological aspects of this disease, and
more education is needed to prevent its occurrence, especially those related to consanguineous marriage.
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Background
Thalassemia is a hemoglobinopathy
which results from a gene mutation in the α
or β chain [1]. It has a preeminent prevalence
in the Mediterranean, tropical areas, and the
regions near the equator [2]. Thalassemia is
one of the most prevalent genetic blood
disorders in the world. Thalassemia affects
4.4 of every 10,000 live births. It affects
males and females equally because it follows
an autosomal pattern of inheritance. Like in
many other countries, thalassemia is an
important public health problem in Palestine,
with approximately 4.3% of the Palestinians
are carriers of the mutations for this disease
[3].

The chronic nature of the disease, its need
for continuous, lengthy and intense
treatments affects all aspects of the
individuals’ life. It has an arduous and
substantial impact on physical, emotional and
mental health as well as the quality of life of
the patients and their families [4]. Diagnosis
of the disease and integrating it into the
family is considered as a predicament, with
different families reacting differently. Most
of the families can adapt with the disease, but
others may not be as successful in this
regard. This may be due to the lack of
knowledge about the disease, also the lack of
support, expensive treatment, and the
resulting mental stress [5].
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In the current time, there are many
treatment options for thalassemia that can
reduce the disease-related mortality, enhance
life expectancy, and improve the quality of
life of thalassemic patients [6]. In the past
twenty years, there has been an increasing
interest in upgrading the quality of life of the
patients, especially those who suffer from
chronic diseases [7]. In contrast with patients
who have short-term injuries, people
suffering from thalassemia have exceedingly
more depressive symptoms and a lower
quality of life. This emphasizes the
importance and need to have mental,
psychiatric and rehabilitation programs with
a goal to elevate the quality of life of
thalassemic patients. There is a significant
incidence of anxiety, depression, aggression
and shyness in thalassemic patients than
healthy children. Furthermore, another study
indicated that anxiety and depression were in
47% of thalassemic patients and this had an
immense impact on self-care and quality of
life [8]. One of the main intents of treatment
is to bolster quality of life by diminishing the
psychological effects of the disease [9].
Compelling advances have been achieved in
thalassemia front, leading to an improved
understanding of genetic control of
hemoglobin, the deformity in the different
forms, the pathophysiology of the disease,
and the advances in treatment [10]. This
considerable development in the diagnosis
and treatment has not been balanced by
progress in psychosocial rehabilitation in
thalassemia patients [11]. Additionally,
thalassemia has an effect on patients at the
physical, emotional and cognitive levels
causing a disruption of what is considered
“having a normal psychosocial life”.
Tremendous attention is needed regarding
issues related to the illness, enduring
complications, the treatment, and the effect
on the quality life. It is a burdening topic that
needs to be researched.
Patients’ perception-related research, in
general, and in thalassemia patients, in
particular, is comparatively limited in
Palestine and elsewhere. Patient perception
has been proven to be a very important
component in shaping psychological aspects.
Our study is the first in Palestine to focus on

this group and it aims to determine the
perceptions and attitudes toward the disease
and its treatment as well as to explore the
concerns, beliefs and feelings of patients and
their immediate family members
METHODS
Study design
A cross-sectional non-interventional, descriptive study design was used. A convenient sample of patients being treated at the
specialty clinic at Al-Wattani Hospital was
chosen. This hospital is a governmental medical hospital providing its services to residents of the northern area of Palestine, especially those having a governmental health
insurance. Patients were recruited in order to
evaluate their perception towards thalassemia. These patients came from different geographical regions including different cities,
villages and camps all over north Palestine.
Researchers approached eligible patients during their treatment visits and explained the
study objectives. Patients who showed interest in participating in the study were asked to
complete a questionnaire in Arabic about
their perception toward thalassemia. The
questionnaire is the well-known Brief-Illness
Perception Questionnaire (B-IPQ), was translated to Arabic, and then back translated to
English by a certified translator. The later
English version was presented to the author
of the B-IPQ and his approval was obtained.
Overall, there were 5 major sections in the
questionnaire regarding personal information,
family history, blood groups, other current
diseases, and patients’ perception. The perception section focused on major aspects
such as the consequence of the disease, time
line, personal control, treatment control,
identity, coherence, emotional representation,
and illness concern. The exact questions
were: 1- How much does your illness affect
your life? 2- how long do you think your illness will continue? 3- how much control do
you have over your illness? 4- how much do
you think your treatment can help your illness? 5- how much do you experience symptoms from your illness? 6- how concerned
are you about your illness? 7-how well do
you feel you understand your illness? And 8how much does your illness affect your emo-
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tionally? Finally, question 9 was to list in
rank-order the three most important factors
that you believe caused your illness.
For items 1, 2, 5, 6, and 8, a higher score
reflects a more threatening view of the illness. While a lower score for items 3, 4, and
7 indicates a more pessimistic view.
The research was approved by the Institutional Review Board (IRB) committee of AnNajah National University. Participants' information for this study remained confidential and within the institution.
Sample size calculation
The sample size was calculated based on a
response rate of 50% and the online Roasoft
online calculator, with a total number of 130
of thalassemia patients attending Al-Wattani
clinic. This calculation reported that the minimum required sample size is 98. In order to
have a greater assurance in generalizing the
findings in Palestine, it was decided to increase the number of surveyed patients to
more than that if possible.
Grading the B-IPQ
A scale from 1-10 accompanied the questionnaire to extract information about different sections. The data from the questionnaire
were entered into Statistical Package of Social Sciences (SPSS) version 20 software for
further analysis. Descriptive statistics using
frequencies and percentages were used to
identify participants’ perception. Chi-square
(χ2) test was performed to examine the relationship among the categorical variables including the relationships between the different characteristics of participants with all
questions included in the questionnaire. In all
statistical analyses, a p-value ≤ 0.05 was considered statistically significant. MannWhitney test was used to compare differences between two independent groups, and was
performed on gender, age, and education
questions. Kruskal-Wallis is a test that can be
used to determine if there are statistically
significant differences between two or more
groups of an independent variable on a continuous or ordinal dependent variable; it was
used for the questions about residency, and
parents’ relationship.

Results
Demographics
A total of 113 thalassemic patients were
included in the study. About half (55; 48.7%)
of the patients were males and the other half
were females (58; 51.3%). The mean age of
the participants was about 21.0±9.5 years
old, with an age range of 12-70 years. Patients have been diagnosed since about 19.4±
7.4 years. The majority have college education (50; 44.2%), a lesser group had only
elementary school education (36; 31.9%),
and the rest had high school education (27;
23.9%). A bit more than half of the participants lived in villages (63; 55.8%), and the
rest lived in cities (31; 27.4%), or camps (19;
16.8%). Blood group analysis for the patients
showed that (62; 54.9%) had blood group A,
(33; 29.2%) had blood group O, and (8;
7.1%) had blood group B, the rest (9; 8%)
were AB blood group. Almost all participants
were generally healthy and mostly did not
have other diseases (111; 98.2%).
Family History
Data analysis pertaining to family history
of the patients indicated that a large percentage (65; 57.5%) of the patients’ parents had
a consanguineous marriage, and about a
quarter (25; 22.1%) were second degree relatives before marriage. The remainder had no
family relationship between their parents before marriage (22; 19.5%).
Perception
Data from the B-IPQ is generally presented as median and interquartile range. In
general, participants reported that they perceive their disease as chronic (timeline) (median of 10, and interquartile range from 1010). Patients reported that the disease has
minimal effect on their quality of life (consequences) (median of 3, and interquartile
range of 0.5-3). Results indicate that participants believe that the treatment can control
their disease to a significant extent (treatment
control) (median of 10, interquartile range
from 8-10), and that they can control their
disease by themselves (personal control)
(median of 8, interquartile range of 7-10).
They reported that they mostly did not experience thalassemia-related health effects

 ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــPalestinian Medical and Pharmaceutical Journal (PMPJ). 2018; 3(1): 7-13

10 “ ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــIllness Perception in Patients with......”

(identity) (median of 2, interquartile range 2tional representation) (median of 3, interquar3), and that they were not very concerned
tile range of 1-4), (Table 1). Testing for norabout their illness (illness concern) (median
mality revealed that data is not normally disof 3, interquartile from 1-4). They also had
tributed based on Shapiro-Wilk test, thus resvery good understanding of their illness (coponses to the eight questions included in the
herence) (median of 8, interquartile range
B-IPQ were not normally distributed, so refrom 6-9), and that they were not strongly
sults are presented as median (interquartile
affected emotionally by thalassemia (emorange).
Table (1): Descriptive statistics of the eight items of the B-IPQ
Brief IPQ item
Consequence
Time line
Personal control
Treatment control
Identity
Illness concern
Understanding
Emotional representation
Data analysis regarding the effect of
gender on perception using Mann -Whitney
Test showed that there was a significant effect of gender on knowledge, with females
having more knowledge about the time
course of the disease (p= 0.041) (Table 2).

Median
Interquartile range
3
0.5-3
10
10-10
8
7-10
10
8-10
2
2-3
3
1-4
8
6-9
3
1-4
Females believed that the treatment can
control the disease more than men (p=0.02),
females were more concerned about the disease compared to males (p=0.013), and females had more understanding the disease
compared to males (p=0.032); (Table 2).

Table (2): The effect on illness perception based on gender, age, education, residence, and the
number of years since diagnosis
Perception item
Consequences
Time line
Personal control
Treatment control
Identity
Illness concern
Understanding
Emotional representation

P value
Gender*
0.052
0.041
0.139
0.020
0.801
0.013
0.032
0.148

Age*
0.002
0.061
0.343
0.309
0.000
0.051
0.000
0.001

Education* Residence* Years since diagnosis*
0.100
0.508
0.002
0.171
0.271
0.101
0.440
0.516
0.004
0.865
0.088
0.213
0.209
0.010
0.000
0.236
0.056
0.009
0.000
0.027
0.000
0.458
0.043
0.001

* Bold text indicates a statistically significant difference with a p-value less than 0.05

As for the effect of age, results show that
it did have an effect on some aspects of perception, and all the significant results were
associated with advancing age. For example,
age had a high significant effect on both the
identity and illness understanding (P values
of 0.000 for both). Age also had a significant
effect on the consequences and the emotional
representation of the disease (P value of
0.002 and 0.001, respectively) (Table 2). Additionally, Kruskal-Wallis test on the effect
of education showed that patients with col-

lege education had significantly higher understanding of the disease (P= 0.000), while
patients with elementary education showed
more significant effects regarding the identity and the emotional representation (P =
0.010 and 0.043, respectively) (Table 2). The
same test revealed and effect of the place of
residence on the perception items. There was
a significant effect for the place of residence
on how much personal control the patients
felt they had (P = 0.004) with city residence
believing they have more. Village residents
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showed more in terms of illness concern (P=
0.009), and illness understanding (P= .027)
(Table 2). Finally, it was found that the longer the time since the patient was diagnosed
with thalassemia the more significant effect
was found on the consequences (P= 0.002),
identity (P= 0.000), understanding (P=
0.000), and emotional representation (P=
0.001) (Table 2).
DISCUSSION
There are many studies in the literature
about patients’ perception of many diseases
in different countries around the world; however, similar studies in a resource-poor country like Palestine do not exist. To our knowledge, this is the first study of its type to assess patient perception of thalassemia in patients affected by this disease, no similar studies were found elsewhere. This study provides a unique opportunity to understand the
psychological aspects of this group of patients. Understanding patients’ perception of
their own condition is a useful way to predict
their behavior, especially with chronic illnesses. All the work on illness perception
was based on a theory that proposes that individuals’ perception of the disease affects
coping with it [12, 13].
For the greatest percentage of participants, their parents were relatives before getting married. This is a current practice among
the local community. The government is
taking strict steps toward decreasing the
emergence of new thalassemia cases by requesting a thalassemia test for couples planning to get married.
Illness perception is expected to increase
adherence to therapy, improves family relations, and reduces inappropriate service use
[14]. In our study, patient did have good
knowledge about several aspects of their disease, such as its time course, which may be
due to the fact that most of them have had the
disease for a long time. Part of the good attitude patients had was because their disease
had minimal effect on their life, based on
their perception. Also, they had strong trust
that their treatment is controlling their symptoms. A false believe they had is their belief
that they can control their symptoms, even
though it is known that thalassemia symp-

toms are not under patients control. An explanation for this could be the fact that they
did not experience thalassemia-related symptoms to start with.
The various illness perception components depend to a certain degree on the symptoms patients have. In our study, patient suffering from thalassemia do not have several
symptoms, thus it did affect their perception.
In our study, patients believed that therapy is
capable of controlling their symptoms, which
is a positive attitude. This is due to the fact
that those patients are regular attendants of
the specialty clinic at Al-Wattani for their
treatment.
The existing literature has shown that patient’s illness beliefs affect clinical outcomes
[15, 16]. Not only that, but also research
among other patient groups have found that
the time to death would be shorter in those
patients who have negative psychological
beliefs [17]. Thus, illness beliefs can predict
survival, with special emphasis on the “identity” variable. The good news is that these
beliefs are modifiable [16, 18-22], an aspect
that should be focused upon by therapists
treating thalassemia patients.
LIMITATIONS
This study has some limitations, for example, it used the B-IPQ and not the extended one, which provides answers about
perceptions but not as detailed as the long
questionnaire. Additionally, this was a pilot
study conducted in Nablus, yet, patients in
other cities may respond differently to the
questions in the questionnaire. Finally, there
was no data about patients’ medications, particularly if they were taking antidepressants.
CONCLUSIONS
In conclusion, these findings showed that
the participants perceive their disease as a
chronic (timeline), yet it had minimal effect
on their quality of life (consequences). They
also believe that the treatment and themselves can control their disease. Incorporating
patients’ perception of thalassemia in the
treatment plan will be worth the effort since
it improves adherences to therapy and decreases mortality. Public education about
thalassemia and the role of consignment mar-
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riage in transferring it to the off spring is
very important.
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